LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 70.08 | 27.76 | 4378 | 6849 | 0.6392 | 0.8905 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 70.08 | 27.76 | 5273 | 6849 | 0.7698 | 0.9352 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 71.78 | 27.76 | 197 | 6893 | 0.0286 | 0.2793 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 71.78 | 27.76 | 5556 | 6893 | 0.8060 | 0.9465 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 71.78 | 27.76 | 3698 | 6893 | 0.5365 | 0.8494 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 71.78 | 27.76 | 5321 | 6893 | 0.7719 | 0.9360 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 73.48 | 27.76 | 233 | 6957 | 0.0335 | 0.3060 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 73.48 | 27.76 | 5712 | 6957 | 0.8210 | 0.9511 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 73.48 | 27.76 | 3669 | 6957 | 0.5273 | 0.8457 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 73.48 | 27.76 | 5457 | 6957 | 0.7843 | 0.9400 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 75.19 | 27.76 | 239 | 7015 | 0.0341 | 0.3096 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 75.19 | 27.76 | 5867 | 7015 | 0.8363 | 0.9557 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 75.19 | 27.76 | 3540 | 7015 | 0.5046 | 0.8358 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 75.19 | 27.76 | 5620 | 7015 | 0.8011 | 0.9452 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 76.89 | 27.76 | 253 | 7025 | 0.0360 | 0.3189 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 76.89 | 27.76 | 5990 | 7025 | 0.8526 | 0.9605 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 76.89 | 27.76 | 3276 | 7025 | 0.4663 | 0.8177 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 76.89 | 27.76 | 5719 | 7025 | 0.8141 | 0.9491 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 78.60 | 27.76 | 227 | 7045 | 0.0322 | 0.3009 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 78.60 | 27.76 | 6115 | 7045 | 0.8679 | 0.9648 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 78.60 | 27.76 | 3396 | 7045 | 0.4820 | 0.8254 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 78.60 | 27.76 | 5830 | 7045 | 0.8274 | 0.9531 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 80.31 | 27.76 | 208 | 6976 | 0.0298 | 0.2874 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 80.31 | 27.76 | 6265 | 6976 | 0.8981 | 0.9732 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 80.31 | 27.76 | 3182 | 6976 | 0.4561 | 0.8125 | MN20160318_Q01 | E11 |